Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.84 Million USD | -44.64% |
| 2022 | 336 Thousand USD | 114.01% |
| 2021 | 157 Thousand USD | 31.93% |
| 2020 | 119 Thousand USD | -13.77% |
| 2019 | 138 Thousand USD | 253.85% |
| 2018 | 39 Thousand USD | -99.2% |
| 2017 | 4.87 Million USD | -57.42% |
| 2016 | 11.44 Million USD | -13.28% |
| 2015 | 13.2 Million USD | -11.12% |
| 2014 | 14.85 Million USD | -2.71% |
| 2013 | 15.26 Million USD | -8.02% |
| 2012 | 16.59 Million USD | 2.64% |
| 2011 | 16.17 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 44 Thousand USD | 388.89% |
| 2024 Q2 | 228 Thousand USD | 1343.18% |
| 2023 Q4 | 9000.00 USD | -98.4% |
| 2023 FY | 186 Thousand USD | -44.64% |
| 2023 Q1 | 122 Thousand USD | -43.78% |
| 2023 Q2 | 131 Thousand USD | 7.38% |
| 2023 Q3 | 561 Thousand USD | 328.24% |
| 2022 Q1 | 21 Thousand USD | -47.5% |
| 2022 Q2 | 14 Thousand USD | -33.33% |
| 2022 Q3 | 84 Thousand USD | 500.0% |
| 2022 Q4 | 217 Thousand USD | 158.33% |
| 2022 FY | 336 Thousand USD | 114.01% |
| 2021 Q3 | 49 Thousand USD | 75.0% |
| 2021 Q1 | 40 Thousand USD | 73.91% |
| 2021 Q2 | 28 Thousand USD | -30.0% |
| 2021 FY | 157 Thousand USD | 31.93% |
| 2021 Q4 | 40 Thousand USD | -18.37% |
| 2020 FY | 119 Thousand USD | -13.77% |
| 2020 Q1 | 41 Thousand USD | -36.92% |
| 2020 Q2 | 41 Thousand USD | 0.0% |
| 2020 Q3 | 13 Thousand USD | -68.29% |
| 2020 Q4 | 23 Thousand USD | 76.92% |
| 2019 Q2 | 34 Thousand USD | 88.89% |
| 2019 Q4 | 65 Thousand USD | 195.45% |
| 2019 FY | 138 Thousand USD | 253.85% |
| 2019 Q1 | 18 Thousand USD | -53.85% |
| 2019 Q3 | 22 Thousand USD | -35.29% |
| 2018 Q1 | 1.76 Million USD | 256.79% |
| 2018 FY | 39 Thousand USD | -99.2% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q4 | 39 Thousand USD | 0.0% |
| 2018 Q2 | 1.51 Million USD | -14.09% |
| 2017 Q1 | 1.96 Million USD | -22.82% |
| 2017 FY | 4.87 Million USD | -57.42% |
| 2017 Q4 | -1.12 Million USD | -172.8% |
| 2017 Q3 | 1.54 Million USD | -37.73% |
| 2017 Q2 | 2.48 Million USD | 26.32% |
| 2016 Q1 | 3.28 Million USD | -2.67% |
| 2016 FY | 11.44 Million USD | -13.28% |
| 2016 Q4 | 2.55 Million USD | -2.41% |
| 2016 Q2 | 3 Million USD | -8.35% |
| 2016 Q3 | 2.61 Million USD | -13.07% |
| 2015 FY | 13.2 Million USD | -11.12% |
| 2015 Q4 | 3.37 Million USD | 5.48% |
| 2015 Q3 | 3.19 Million USD | -6.5% |
| 2015 Q2 | 3.41 Million USD | 6.09% |
| 2015 Q1 | 3.22 Million USD | 32.44% |
| 2014 Q1 | 4.13 Million USD | 12.32% |
| 2014 FY | 14.85 Million USD | -2.71% |
| 2014 Q4 | 2.43 Million USD | -40.08% |
| 2014 Q3 | 4.05 Million USD | -4.11% |
| 2014 Q2 | 4.23 Million USD | 2.47% |
| 2013 Q1 | 3.3 Million USD | 16.58% |
| 2013 Q3 | 3.56 Million USD | -24.62% |
| 2013 Q4 | 3.67 Million USD | 3.28% |
| 2013 Q2 | 4.72 Million USD | 42.85% |
| 2013 FY | 15.26 Million USD | -8.02% |
| 2012 Q3 | 5.29 Million USD | 0.0% |
| 2012 FY | 16.59 Million USD | 2.64% |
| 2012 Q4 | 2.83 Million USD | -46.42% |
| 2011 FY | 16.17 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 27.725% |
| BrainsWay Ltd. | 23.09 Million USD | 92.019% |
| Cerus Corporation | 86.4 Million USD | 97.867% |
| Envoy Medical, Inc. | -473 Thousand USD | 489.641% |
| electroCore, Inc. | 13.22 Million USD | 86.065% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -2921.311% |
| IceCure Medical Ltd | 1.3 Million USD | -41.769% |
| Inogen, Inc. | 126.69 Million USD | 98.545% |
| OrthoPediatrics Corp. | 111.25 Million USD | 98.343% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 130.463% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 3993.443% |
| MaxCyte, Inc. | 36.54 Million USD | 94.957% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -303.709% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2066.706% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.621% |
| PAVmed Inc | -3.96 Million USD | 146.447% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 133.601% |
| RxSight, Inc. | 53.76 Million USD | 96.572% |
| Sight Sciences, Inc. | 69.17 Million USD | 97.336% |
| SI-BONE, Inc. | 109.42 Million USD | 98.316% |
| TELA Bio, Inc. | 40.11 Million USD | 95.405% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 98.787% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 77.717% |
| Acutus Medical, Inc. | -3.13 Million USD | 158.75% |
| Talis Biomedical Corporation | 371 Thousand USD | -396.765% |
| Spectral AI, Inc. | 7.88 Million USD | 76.612% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 127.958% |
| CVRx, Inc. | 33.03 Million USD | 94.422% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -149.214% |
| Bioventus Inc. | 328.19 Million USD | 99.438% |
| Venus Concept Inc. | 52.16 Million USD | 96.467% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 88.413% |
| LivaNova PLC | 771.25 Million USD | 99.761% |
| 908 Devices Inc. | 25.32 Million USD | 92.722% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.406% |
| Nemaura Medical Inc. | -1.47 Million USD | 224.831% |
| NeuroPace, Inc. | 48.12 Million USD | 96.17% |
| LENSAR, Inc. | 21.1 Million USD | 91.268% |
| Apyx Medical Corporation | 14.12 Million USD | 86.949% |
| Cutera, Inc. | 41.49 Million USD | 95.558% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 90.017% |
| BioSig Technologies, Inc. | 18 Thousand USD | -10138.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 98.212% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 86.462% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.793% |
| Axonics, Inc. | 274.55 Million USD | 99.329% |
| Outset Medical, Inc. | 29 Million USD | 93.645% |
| IRIDEX Corporation | 21.8 Million USD | 91.549% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 97.406% |
| IRadimed Corporation | 50.15 Million USD | 96.326% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -542.16% |
| INVO Bioscience, Inc. | 1.08 Million USD | -69.684% |
| Telesis Bio, Inc. | 16.95 Million USD | 89.127% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 98.366% |
| Varex Imaging Corporation | 256.9 Million USD | 99.283% |
| Quipt Home Medical Corp. | 163.84 Million USD | 98.875% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 553.941% |
| Pulmonx Corporation | 50.75 Million USD | 96.369% |
| Dynatronics Corporation | 7.63 Million USD | 75.861% |
| Modular Medical, Inc. | -768 Thousand USD | 339.974% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 66.781% |
| Semler Scientific, Inc. | 61.2 Million USD | 96.989% |
| InMode Ltd. | 411.34 Million USD | 99.552% |
| Bruker Corporation | 1.51 Billion USD | 99.878% |
| Cytosorbents Corporation | 22.39 Million USD | 91.769% |
| DexCom, Inc. | 2.28 Billion USD | 99.919% |
| Align Technology, Inc. | 2.71 Billion USD | 99.932% |
| Viveve Medical, Inc. | 620 Thousand USD | -197.258% |
| ZimVie Inc. | 290.38 Million USD | 99.365% |
| Movano Inc. | -158 Thousand USD | 1266.456% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 98.316% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2066.706% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.499% |
| Profound Medical Corp. | 4.51 Million USD | 59.172% |
| Insulet Corporation | 1.15 Billion USD | 99.841% |
| enVVeno Medical Corporation | -546 Thousand USD | 437.546% |
| Surmodics, Inc. | 93.05 Million USD | 98.019% |
| iCAD, Inc. | 14.53 Million USD | 87.321% |
| Nuwellis, Inc. | 4.98 Million USD | 63.014% |
| Biotricity, Inc. | 8.35 Million USD | 77.945% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.445% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 613.289% |
| InspireMD, Inc. | 1.8 Million USD | -1.992% |
| PAVmed Inc. | -3.96 Million USD | 146.447% |
| BIOLASE, Inc. | 16.72 Million USD | 88.98% |
| Beyond Air, Inc. | -1.3 Million USD | 241.01% |
| FONAR Corporation | 45.14 Million USD | 95.917% |
| AxoGen, Inc. | 127.87 Million USD | 98.559% |
| Vivani Medical, Inc. | -357 Thousand USD | 616.246% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.056% |
| Inari Medical, Inc. | 434.56 Million USD | 99.576% |
| UFP Technologies, Inc. | 112.22 Million USD | 98.358% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -14621.623% |
| Tenon Medical, Inc. | 1.24 Million USD | -48.509% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 2375.309% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 29.846% |
| AdaptHealth Corp. | 479.56 Million USD | 99.616% |
| NanoVibronix, Inc. | 1.53 Million USD | -19.909% |
| Quanterix Corporation | 70.64 Million USD | 97.391% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 553.941% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 86.892% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 96.508% |
| TransMedics Group, Inc. | 154.09 Million USD | 98.804% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 58.612% |
| NeuroMetrix, Inc. | 3.94 Million USD | 53.311% |
| Hyperfine, Inc. | 4.75 Million USD | 61.257% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 98.277% |
| Biomerica, Inc. | 611 Thousand USD | -201.637% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 95.579% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 335.993% |
| Silk Road Medical, Inc | 127.08 Million USD | 98.55% |